"Situé dans un cadre agréable de 8 hectares, le Pôle Santé Léonard de Vinci s’inscrit comme l’un des plus grands établissements de Santé privés de France. La clinique est dotée de toutes les structures nécessaires pour vous faire bénéficier sur un même lieu d'une prise en charge globale et continue. La clinique Léonard de Vinci vous propose une offre de soins organisée autour de 4 pôles : le pôle Maternité le pôle Chirurgie le pôle Médecine / Soins palliatifs le pôle Cancérologie Elle propose également une offre de Soins de Suite et de Réadaptation."

During the past decade, Pôle Santé Léonard de Vinci conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pôle Santé Léonard de Vinci" #1 sponsor was "Federation Francophone de Cancerologie Digestive" with 2 trials, followed by "Ferring Pharmaceuticals" with 2 trials sponsored, "Intergroupe Francophone de Cancerologie Thoracique" with 2 trials sponsored, "UNICANCER" with 2 trials sponsored and "Association Francaise d'Urologie" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pôle Santé Léonard de Vinci" #1 collaborator was "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Association Francophone des Soins Oncologiques de Support" with 1 trials as a collaborator, "Association de Neuro-Oncologues d'Expression Francaise" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Pôle Santé Léonard de Vinci" are "Carcinoma, Non-Small-Cell Lung" (2 trials), "Prostate Cancer" (2 trials), "Surgery" (2 trials), "ALK Gene Mutation" (1 trials) and "BRAF Gene Mutation" (1 trials). Many other conditions were trialed in "Pôle Santé Léonard de Vinci" in a lesser frequency.

Most popular intervention types in "Pôle Santé Léonard de Vinci" are "Drug" (4 trials), "Procedure" (4 trials), "Device" (2 trials), "Other" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "3-dimensional conformal radiation therapy" (1 trials), "Altis Single Incision Sling" (1 trials), "Blood sample for phenotypic and pharmacogenetic analysis." (1 trials), "Chemotherapy with platine" (1 trials) and "Chemotherapy without Cisplatine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pôle Santé Léonard de Vinci" are 11 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Pôle Santé Léonard de Vinci". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Pôle Santé Léonard de Vinci, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Pôle Santé Léonard de Vinci, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".